VIENNA – Prior to ECR 2024, there was intense speculation that Prof. Dr. Alex Radbruch, JD, might soon be taking up a post at the Charité in Berlin. In a video interview, he comments on this speculation and also discusses the current evidence on brain retention and gadolinium-based MRI contrast agents. Do they pose a serious threat to patient safety today? And by how much can AI reduce gadolinium dose in the years to come?
Radbruch is currently chair of diagnostic and interventional neuroradiology and professor at Rheinische Friedrich Wilhelms University Bonn, Germany. He has also been an active member of the Editorial Advisory Board of AuntMinnieEurope.com since the site's launch at ECR 2011.
Video and homepage photo produced by Christof.G.Pelz | GRAFIFANT Creation | www.grafifant.at | 2024
